IGFBP1 and metabolic dysfunction-associated steatohepatitis: On the mRNA level, insulin-like growth factor binding protein 1 (IGFBP1) and fatty acid CoA ligase 4 (FACL4) were differentially expressed between NASH and steatotic patients.